To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Pierre Åman - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Pierre Åman

Professor

Pierre Åman
Professor
pierre.aman@llcr.med.gu.se
+46 31 786 6732
0706-846085

Postal Address: Box 425, 40530 Göteborg
Visiting Address: Medicinaregata 1F , 41390 Göteborg


Department of Laboratory Medicine at Institute of Biomedicine (More Information)
Sahlgrenska universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 8 , 413 45 Göteborg

Latest publications

JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
Soheila Dolatabadi, Emma Jonasson, Malin Lindén, Bentolhoda Fereydouni, Karin Bäcksten et al.
International Journal of Cancer, Journal article 2019
Journal article

Requirement for YAP1 signaling in myxoid liposarcoma.
Marcel Trautmann, Ya-Yun Cheng, Patrizia Jensen, Ninel Azoitei, Ines Brunner et al.
EMBO molecular medicine, Journal article 2019
Journal article

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
Malin Lindén, Christer Thomsen, Pernilla Grundevik, Emma Jonasson, Daniel Andersson et al.
EMBO Reports, Journal article 2019
Journal article

Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma
M. Trautmann, M. Cyra, I. Isfort, B. Jeiler, A. Kruger et al.
Molecular Cancer Therapeutics, Journal article 2019
Journal article

Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
David Svec, Soheila Dolatabadi, Christer Thomsen, Nicole Cordes, Mark Shannon et al.
Laboratory investigation; a journal of technical methods and pathology, Journal article 2018
Journal article

FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma
M. Trautmann, J. Menzel, C. Bertling, M. Cyra, I. Isfort et al.
Clinical Cancer Research, Journal article 2017
Journal article

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
Michaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, Sebastian Bauer, Nancy Ratner et al.
The journal of pathology. Clinical research, Journal article 2016
Journal article

Showing 21 - 30 of 53

2012

Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153
Alexandra Jauhiainen, Christer Thomsen, Linda Strömbom, Pernilla Grundevik, Carola Andersson et al.
PLoS ONE, Journal article 2012
Journal article

The first European interdisciplinary ewing sarcoma research summit.
Heinrich Kovar, Javier Alonso, Pierre Åman, Dave N T Aryee, Jozef Ban et al.
Frontiers in oncology, Journal article 2012
Journal article

2011

2010

2009

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors.
Claudia Forni, Mario Minuzzo, Emanuela Virdis, Elena Tamborini, Matteo Simone et al.
Molecular cancer therapeutics, Journal article 2009
Journal article

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.
R Shah, P Smith, C Purdie, P Quinlan, L Baker et al.
British journal of cancer, Journal article 2009
Journal article

Showing 21 - 30 of 53

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?